Nature Communications (Sep 2022)

Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37

  • Rens Peeters,
  • Jorge Cuenca-Escalona,
  • Esther A. Zaal,
  • Anna T. Hoekstra,
  • Anouk C. G. Balvert,
  • Marcos Vidal-Manrique,
  • Niek Blomberg,
  • Sjoerd J. van Deventer,
  • Rinke Stienstra,
  • Julia Jellusova,
  • Martin Giera,
  • Luciana Hannibal,
  • Ute Spiekerkoetter,
  • Martin ter Beest,
  • Celia R. Berkers,
  • Annemiek B. van Spriel

DOI
https://doi.org/10.1038/s41467-022-33138-7
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 18

Abstract

Read online

Tetraspanin CD37 deficiency has been reported as a prognostic marker for aggressive B-cell lymphoma. Here, the authors show that CD37 interacts with the fatty acid transporter 1 to inhibit palmitate uptake and its deficiency leads to increased fatty acid metabolism which promotes tumorigenesis in B-cell lymphoma.